当前位置:首页 - 行情中心 - 华纳药厂(688799) - 财务分析 - 现金流量表

华纳药厂

(688799)

  

流通市值:59.58亿  总市值:59.58亿
流通股本:1.34亿   总股本:1.34亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金852,820,295.62578,869,749.4310,679,596.651,362,698,491.4
  收到的税费返还675,093.55401,793.0762,463.281,000,079.73
  收到其他与经营活动有关的现金37,918,266.0726,972,367.278,562,493.3434,063,501.25
  经营活动现金流入小计891,413,655.24606,243,909.74319,304,553.271,397,762,072.38
  购买商品、接受劳务支付的现金77,589,477.5946,923,177.7219,966,850.74203,812,379.43
  支付给职工以及为职工支付的现金148,244,242.86105,829,955.0659,207,513.62187,037,942.28
  支付的各项税费69,640,035.2460,721,021.0940,106,020.17143,824,402.8
  支付其他与经营活动有关的现金318,380,175.56226,034,770.02126,971,151.12562,886,837.21
  经营活动现金流出小计613,853,931.25439,508,923.89246,251,535.651,097,561,561.72
  经营活动产生的现金流量净额277,559,723.99166,734,985.8573,053,017.62300,200,510.66
二、投资活动产生的现金流量:
  收回投资收到的现金939,839,509.59569,839,509.59100,041,273.97627,000,000
  取得投资收益收到的现金8,327,709.917,929,630.62142,293.8818,137,063.94
  处置固定资产、无形资产和其他长期资产收回的现金净额13,000--74,763.89
  处置子公司及其他营业单位收到的现金净额---5,969,037.05
  投资活动现金流入小计948,180,219.5577,769,140.21100,183,567.85651,180,864.88
  购建固定资产、无形资产和其他长期资产支付的现金395,740,603.69299,374,117.86188,689,970.43520,318,123.84
  投资支付的现金1,171,959,422.81643,029,651.12170,000,000733,472,605.56
  支付其他与投资活动有关的现金---6,564,840.11
  投资活动现金流出小计1,567,700,026.5942,403,768.98358,689,970.431,260,355,569.51
  投资活动产生的现金流量净额-619,519,807-364,634,628.77-258,506,402.58-609,174,704.63
三、筹资活动产生的现金流量:
  吸收投资收到的现金28,797,99328,797,993-14,974,383
  取得借款收到的现金820,826,051.79735,291,891.71174,398,227383,995,846.4
  筹资活动现金流入小计849,624,044.79764,089,884.71174,398,227398,970,229.4
  偿还债务支付的现金460,852,974.71460,852,974.71--
  分配股利、利润或偿付利息支付的现金37,483,256.1519,238,800.153,817,650.1262,964,210.34
  筹资活动现金流出小计498,336,230.86480,091,774.863,817,650.1262,964,210.34
  筹资活动产生的现金流量净额351,287,813.93283,998,109.85170,580,576.88336,006,019.06
四、汇率变动对现金及现金等价物的影响-1,990,020.13-1,366,483.74-645,151.4-993,338.01
五、现金及现金等价物净增加额7,337,710.7984,731,983.19-15,517,959.4826,038,487.08
  加:期初现金及现金等价物余额201,478,427.66201,478,427.66201,478,427.66175,439,940.58
  期末现金及现金等价物余额208,816,138.45286,210,410.85185,960,468.18201,478,427.66
补充资料:
  净利润-64,599,830-228,098,328.6
  资产减值准备-1,065,215.97-8,833,358.42
  固定资产和投资性房地产折旧-37,342,389.79-67,181,107.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-37,342,389.79-67,181,107.74
  无形资产摊销-3,160,173.25-3,869,641.72
  长期待摊费用摊销-3,375,479.56-5,775,744.92
  处置固定资产、无形资产和其他长期资产的损失---413.06
  固定资产报废损失---27,257.84
  财务费用-1,160,309.04-1,640,703.7
  投资损失--3,203,427.26--84,456,255.41
  递延所得税-5,948,498.4-1,358,727.34
  其中:递延所得税资产减少-5,948,498.4-1,382,829.87
    递延所得税负债增加----24,102.53
  存货的减少-11,073,806.21-11,073,650.88
  经营性应收项目的减少-591,941.49--56,444,183.31
  经营性应付项目的增加-34,829,875.54-60,410,018.76
  其他---51,964,641.89
  现金的期末余额-286,210,410.85-201,478,427.66
  减:现金的期初余额-201,478,427.66-175,439,940.58
  现金及现金等价物的净增加额-84,731,983.19-26,038,487.08
公告日期2026-10-312026-08-252026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑